- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-07-01-2021
Navigating PV Divergence: Compliance Tips for New Entrants
July 08, 2021
Features
41
7
With small biotechs facing similar expectations as large pharma in drug safety and pharmacovigilance, despite less resources, identifying the key differences between US and EU requirements can help these companies craft a practical path to multi-region compliance.
The Diversity Mindset: Benefits of Tapping External Sources
July 08, 2021
Features
41
7
Seeking opportunities to be more inclusive can help pharma companies gain a deeper understanding of key opinion leader and patient perspectives and build diversity into the entire product journey.
Firsthand Views: Latinos in Pharma
July 08, 2021
Features
41
7
Latino executives share their experiences and insights on the community’s contributions to the life sciences industry.
Building Belonging: Pharma’s New Focus in DE&I
July 08, 2021
Features
41
7
Along with the industry’s massive effort to tackle the health and social problems exposed by COVID, pharma companies have spent the last year addressing the internal impact of racial inequalities following the murder of George Floyd.
Coach First, CEO Second
July 08, 2021
Executive Profile
41
7
Influenced by lessons from the playing field, former rugby athlete James Robinson, today president and CEO of Urovant Sciences, discusses the keys to establishing a high-performing team culture in biopharma—and the end-game wins in treatment gain and patient need.
Today’s Accelerated Pace of Innovation: Can We Afford It?
July 08, 2021
Finance
41
7
A remarkable run indeed, but cost questions can’t be ignored.
The Data Challenge in Rare Diseases and Complex Therapies
July 08, 2021
Technology
41
7
Closing the gaps in complex therapy data remains a hurdle, but “getting clever” with AI can offer a path forward.
The Advantages of Stepping Back to Let Others Step Up
July 08, 2021
Leadership
41
7
Give your team members opportunities to lead for greater growth.
COVID Blame Games Give Way to Lesson Learning
July 08, 2021
Europe Report
41
7
Summits, proposals outline advice on response to future pandemics.
Biden Budget ‘Wish List’ Maps FDA, Healthcare Priorities
July 08, 2021
Washington Report
41
7
White House backs big boost in funding for research, public health.
Opposing Short-Termism
July 08, 2021
From the Editor
41
7
Recent roundtable highlights need for biopharma to enter ESG conversation.
Questions Linger on COVID’s Origin
July 08, 2021
Chairman’s Letter
41
7
Debate on origin of virus responsible for global pandemic continues on.
Pharmaceutical Executive, July 2021 Issue (PDF)
July 08, 2021
Issue PDF
41
7
Click the title above for a link to open the Pharmaceutical Executive July 2021 issue in an interactive PDF format.
Time for Pharma to Reimagine the Medical Affairs Role
June 09, 2021
Back Page
41
7
Commercial-model shift demanding greater influence of these teams.
Digital-Deal Alignment: Considerations for Tech Agreements
May 13, 2021
Features
41
7
The eight key areas biopharma manufacturers must stay on top of when planning and executing alliance agreements with prospective digital health partners.